Relationship of ferritin and hepcidin with disease severity in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus

Liver Int. 2023 Nov;43(11):2571-2575. doi: 10.1111/liv.15747. Epub 2023 Sep 27.

Authors

Claudia Cravo¹, Cristiane A Villela-Nogueira^{1

2}, Ana Carolina Cardoso¹, Renata M Perez^{1

2

3}, Nathalie C Leite^{1

2}

Affiliations

¹ Hepatology Division, Clementino Fraga Filho University Hospital, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
² Internal Medicine Department, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
³ D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.

PMID: 37752888
DOI: 10.1111/liv.15747

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Diabetes Mellitus, Type 2* / complications
Ferritins
Hepcidins
Humans
Non-alcoholic Fatty Liver Disease* / complications
Patient Acuity

Substances

Ferritins
Hepcidins